Technology Transfer Pitfalls in Intermediate Projects: Avoid Costly Mistakes
This article breaks down the 4 most costly mistakes — including incomplete documentation and ignored scalability — with verified industry data and real cases.
TAF Intermediates; Tenofovir Alafenamide(GS-7340); GS7340/GS7340; GS-7340 Tenofovir alafenamide; GS-7340-03; L-Alanine,N-[(S)-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]phenoxyphosphinyl]-,1-methylethylester
CAS:379270-37-8
Chemical Formula:C21H29N6O5P
Molecular Weight:476.47
Availability: R&D; Commercialization
⬤ CAS No.379270-37-8
⬤ Packaging type:20kg barrel;5kg barrel;1kg bag;500g bag ; Customized Packaging
| Product Name | Tenofovir Alafenamide |
| CAS No. | 379270-37-8 |
| Chemical Formula | C21H29N6O5P |
| Molecular Weight | 476.47 |
| EINECS | 1592732-453-0 |
| Related Categories | Intermediates; Pharmaceutical raw materials |
| Melting Point | >119°C (dec.) |
| Boiling Point | 640.4±65.0 °C(Predicted) |
| Density | 1.39±0.1 g/cm3(Predicted) |
| Acidity Coefficient (pKa) | 4.21±0.10(Predicted) |
| Storage Conditions | 2-8°C(protect from light) |
| Solubility | Soluble in chloroform (a little), DMSO (a little), methanol (a little) |
| Form | Solid |
| Color | White to off-white |
| Stability | Hygroscopicity |
| InChIKey | LDEKQSIMHVQZJK-QTJFZWIYNA-N |
| Biological Activity | Tenofovir alafenamide is a new type of nucleotide reverse transcriptase inhibitor. |
| Application | Tenofovir alafenamide is a prodrug of tenofovir (T018500), a reverse transcriptase inhibitor used to treat HIV and hepatitis B. |
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
This article breaks down the 4 most costly mistakes — including incomplete documentation and ignored scalability — with verified industry data and real cases.
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
Drawing from on-the-ground experience in China’s top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when to buy from the workhorses of mature production.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.